Amal Ltd
Incorporated in 1974, Amal Ltd manufactures bulk chemicals and their downstream products[1]
- Market Cap ₹ 1,252 Cr.
- Current Price ₹ 1,013
- High / Low ₹ 1,148 / 296
- Stock P/E 32.7
- Book Value ₹ 80.2
- Dividend Yield 0.10 %
- ROCE 36.0 %
- ROE 34.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 27.3% CAGR over last 5 years
Cons
- Stock is trading at 12.6 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.22% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|
33 | 30 | 43 | 61 | 86 | 135 | 162 | |
19 | 19 | 40 | 67 | 71 | 92 | 110 | |
Operating Profit | 14 | 11 | 4 | -6 | 15 | 43 | 52 |
OPM % | 43% | 37% | 9% | -9% | 18% | 32% | 32% |
2 | 1 | 0 | 1 | 0 | 1 | 1 | |
Interest | 2 | 1 | 1 | 4 | 4 | 2 | 1 |
Depreciation | 1 | 1 | 2 | 7 | 9 | 9 | 9 |
Profit before tax | 13 | 11 | 2 | -16 | 3 | 33 | 42 |
Tax % | 28% | 19% | 31% | 3% | 39% | 10% | |
9 | 9 | 1 | -16 | 2 | 29 | 38 | |
EPS in Rs | 7.41 | 7.10 | 0.90 | -13.03 | 1.38 | 23.69 | 30.93 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 46% |
TTM: | 81% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 198% |
TTM: | 697% |
Stock Price CAGR | |
---|---|
10 Years: | 47% |
5 Years: | 53% |
3 Years: | 52% |
1 Year: | 175% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 9% |
3 Years: | 7% |
Last Year: | 35% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 9 | 12 | 12 | 12 |
Reserves | 16 | 25 | 26 | 56 | 58 | 87 |
4 | 6 | 51 | 35 | 24 | 0 | |
4 | 8 | 14 | 15 | 13 | 22 | |
Total Liabilities | 34 | 48 | 100 | 118 | 106 | 122 |
10 | 9 | 14 | 90 | 86 | 80 | |
CWIP | 0 | 7 | 66 | 1 | 1 | 0 |
Investments | 15 | 20 | 0 | 0 | 1 | 20 |
10 | 12 | 19 | 27 | 19 | 21 | |
Total Assets | 34 | 48 | 100 | 118 | 106 | 122 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
14 | 10 | -1 | -10 | 21 | 50 | |
-5 | -11 | -43 | -16 | -9 | -22 | |
-9 | 0 | 44 | 29 | -14 | -25 | |
Net Cash Flow | 0 | 0 | -0 | 3 | -2 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 80 | 58 | 11 | 25 | 23 | 27 |
Inventory Days | 38 | 53 | 34 | 26 | 28 | 33 |
Days Payable | 97 | 120 | 42 | 31 | 36 | 68 |
Cash Conversion Cycle | 21 | -10 | 4 | 21 | 15 | -9 |
Working Capital Days | 49 | 6 | 26 | 21 | 17 | 41 |
ROCE % | 33% | 4% | -12% | 7% | 36% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Directorate
11 Jul - Appointment of Dr. Mahabaleshwar Palekar as independent director from Aug 1, 2025 for five years.
-
Unaudited Standalone And Consolidated Financial Results With Limited Review Report For The Quarter Ended June 30, 2025 And Appointment Of Director
11 Jul - Q1 FY2025-26 results: standalone profit ₹18.79L, consolidated profit ₹940.32L; new independent director appointed.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Jul - Certificate confirming share dematerialisation for quarter ended June 30, 2025 under SEBI regulations.
- Closure of Trading Window 26 Jun
-
Board Meeting Intimation for Meeting Of The Board And Closure Of Trading Window
26 Jun - Board meeting on July 11 for Q1 results; trading window closed July 1-13, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2][3]
Amal, originally promoted by the Piramal Group, is now controlled by Atul Ltd, which holds a 49.86% stake through Atul Finserv Ltd. Registered as a small manufacturing company under the MSME Act, Amal produces bulk chemicals like sulphuric acid, oleum, and their derivatives. It also owns Amal Speciality Chemicals Ltd.